High Deviation rates between local and central HER2 assessment and survival with anti-HER2-therapy in advanced Gastric Cancer (GC): Results from the VARIANZ study Conference

Lordick, F, Haffner, I, Luber, B et al. (2018). High Deviation rates between local and central HER2 assessment and survival with anti-HER2-therapy in advanced Gastric Cancer (GC): Results from the VARIANZ study . 41 191-191.

Industry Collaboration

cited authors

  • Lordick, F; Haffner, I; Luber, B; Maier, D; Geier, B; Raimundez, E; Hasenauer, J; Kretzschmar, A; von Weikersthal, LF; Ahlborn, M; Riera, J; Rau, B; Siegler, G; Fuxius, S; Decker, T; Schierle, K; Wittekind, C

authors

publication date

  • January 1, 2018

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

publisher

  • KARGER

start page

  • 191

end page

  • 191

volume

  • 41